-
Advances in new research on the bioimmune anti-cancer drug YS-ON-001
Time of Update: 2020-06-10
Today, the company, the http:// Pharmaceutical (http:// Limited , announced http:// that the company's immuno-cancer drug (http:// YS-ON-001 has made new research progress, with excellent tum
-
Fda has janson TREMFYA ® One-Press for treatment of moderate to severe plaque psoriasis
Time of Update: 2020-06-10
recently http:// , the U.S FDA (http:// has approved the company's TREMFYA ® One-Press, a one-time, single-dose patient self-controlled syringe for the treatment of moderate to severe plaque psor
-
Xi'an Yangsen Yiyi (Ibtini capsule) New indications approved by the State Drug Administration
Time of Update: 2020-06-10
today, The of Johnson and Corporation (http:// Xi'an Yangsen Pharmaceutical Co., Ltd., a subsidiary of china's Pharmaceutical (http:// announced that its new indications of Eyre (ibitini capsu
-
Aerie's glaucoma drug Rocklatan (netarsudil/latanoprost) gets FDA approval
Time of Update: 2020-06-10
, a of the http:// ( http:// announced that the U.S Food and Medicines (http:// Administration ( FDA (http:// ) had approved the company's glauselsud/latanoprost eye solution, 0.02%/0.005 p
-
FDA grants AK1/2 inhibitor Olumiant (baricitinib) fast-track eligibility to treat systemic lupus erythematosus
Time of Update: 2020-06-10
recently , http:// giant Eli Lilly and partner Incyte http:// announced that the u.S Food and Drug (http:// Administration ( ) of the FDA (http:// had granted JAK1/2 inhibitor, The Baricit
-
FDA approves Tosymra (Shumaqutan nasal spray, 10mg) for continued treatment of migraines in adults
Time of Update: 2020-06-10
recently, Dr Reddy, of the http:// pharmaceutical in India, said: "It's not a good time Reddy's Laboratories Ltd and sub- company (http:// Promius Pharma announced that the U.S Food and Drug
-
FDA grants Enzyvant's RVT-801 rare pediatric disease eligibility and fast-track eligibility
Time of Update: 2020-06-10
Farber disease is a rare and considered significantly underdiagnosed disease, often misdiagnosed as juvenile isopathic arthritis The disease is caused by mutations in the ASAH1 gene, which cause the
-
FDA approves Advair Diskus debut sugo
Time of Update: 2020-06-10
asthma is a chronic lung disease in which the airways of patients develop inflammation and narrow, leading to repeated chest tightness, shortness of breath, cough and other symptoms today, the FDA
-
FDA grants Agios' target cancer drug Tibsovo (ivosidenib) breakthrough drug
Time of Update: 2020-06-10
recently, the u.S leading cancer bio pharmaceutical company (http:// http:// Agios announced that the U.S Food and Drug (http:// Administration ( FDA (http:// ) has granted the targeted an
-
Human Fu Pharma gets eligibility for production and sale of mcequicalol softgel sofones in the United States
Time of Update: 2020-06-10
recently, , http:// Pharmaceuticals (http:// Holdings Company (http:// Puracap Pharmaceutical LLC ("Puck," usa, which holds a 72% stake in The Company) received an approval number from the FDA
-
Bacilli State PD-1 inhibitor tislelizumab shows remarkable efficacy in the treatment of classic Hodgkin lymphoma
Time of Update: 2020-06-10
recently, Baiji Shenzhou released a key clinical data at the of the ASH Conference (http:// whose PD-1 inhibitor tislelizumab showed remarkable efficacy in treating classic Hodgkin's lymphoma wit
-
FDA approves Mercado PD-1 inhibitor KEYTRUDA for melanoma patients with metastasis after total excision
Time of Update: 2020-06-10
recently, Mercado announced that the United States The FDA (http:// the results of the trial (http:// based on EORTC1325/KEYNOTE-054, and approved its PD-1 inhibitor KEYTRUDA for use in melano
-
ROMEG Therapeutics' autumn daffodil oral liquid GLOPERBA obtains FDA approval
Time of Update: 2020-06-10
acute gout is a common and complex form of arthritis caused by excessive uric acid production or poor uric acid excretion The most common pathogenesis of acute gout is in the big toe, where some pat
-
FDA approves Keytruda's new indications for treatment of Meckel cell carcinoma
Time of Update: 2020-06-10
recently, the U.S FDA (http:// accelerated the approval of PD-1 tumor immunotherapy Keytruda (Chinese commodity name: Corida, generic name: Pablo Zumat) and a new indication for the treatment of
-
FDA accepts Mercadon KEYTRUDA single drug or combined platinum and 5-fluoromyacil for HNSCC supplementary biological products listing application
Time of Update: 2020-06-10
head and neck cancer refers to a variety of different tumors around the throat, nose, sinuses and mouth Most head and neck cancers are squamous cell carcinomas that begin with flat squamous cells th
-
Samsung Bioepis biosimilar Eticovo gets FDA approval
Time of Update: 2020-06-10
recently, Samsung Bioepis company (http:// announced that its bio- pharmaceutical (http:// Eticovo (http:// was approved by the u.S FDA (http:// the drug is a biosimilar of Amgen and Pfize
-
European Commission approves Bayer Jivi (BAY94-9027) for treatment of haemophiliacs type A
Time of Update: 2020-06-10
Hemophilia Type A is also known as clotting factor VIII defect or classic haemophilia, a recessive hermorrhage disease caused by x-chromosome chain coagulation factor VIII or molecular structure abn
-
Bayer reports results of key Phase 3 clinical trial in new drug darolutamide
Time of Update: 2020-06-10
prostate cancer is the second most common malignant tumor in men worldwide and the fifth leading cause of cancer death in men recently, Bayer (http:// reported the results of its critical Phase
-
FDA approves Roche Tecentriq combination therapy for NSCLC patients
Time of Update: 2020-06-10
234,000 newly diagnosed lung cancer cases in the United States in 2018, according to estimates by the American Cancer Society Lung cancer can be divided into two categories, non-small cell lung canc
-
FDA approves Lynparza as a maintenance therapy for patients with advanced ovarian cancer with BRCA mutation (BRCAm)
Time of Update: 2020-06-10
recently, http:// giant AstraZeneca, the uk's pharmaceutical (http:// and partner Merck and Co announced that the u.S Food and Drug (http:// Authority ( FDA (http:// ) had approved Lynparza
